Medications

Treating C. difficile infections: New purpose for an old drug?

Common in hospitals and nursing homes, Clostridioides difficile infection (CDI) is a major health threat, particularly for older patients. According to a 2015 study by the Centers for Disease Control and Prevention, in the ...

Medical research

Discovery may lead to safer drugs to save more women in childbirth

Postpartum hemorrhaging is the world's leading cause of death for women during and after childbirth, and the third-leading cause in the United States alone. Many doctors in developing countries have turned to the drug misoprostol ...

Obstetrics & gynaecology

New study examines effectiveness of labor induction in India

Researchers from the University of Liverpool with colleagues from Gynuity Health Care in New York and the Government Medial College, Nagpur, India, have published a major study of two different types of labour induction methods ...

Cardiology

Taking misoprostol along with NSAIDs reduces cardiovascular risk

People who took the drug misoprostol for stomach ulcers along with non-steroidal anti-inflammatory (NSAID) drugs had a significantly lower risk of serious cardiovascular events, stroke and kidney failure than those who took ...

Obstetrics & gynaecology

Misoprostol doesn't cut risk of postpartum hemorrhage

(HealthDay)—For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology.

Obstetrics & gynaecology

Preventing postpartum hemorrhage

Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to trial results published ...

Obstetrics & gynaecology

Novel misoprostol insert reduces labor time, need for oxytocin

(HealthDay)—Use of a 200-microgram misoprostol vaginal insert significantly reduces the time to vaginal delivery and the need for oxytocin, in women with an unfavorable cervix, compared to those using a dinoprostone vaginal ...

page 1 from 2